Acipimox-13C2,15N2

Acipimox-13C2,15N2 is a chemical compound that is used in medical research to study the mechanisms of lipid and glucose metabolism in the body. It is a labeled form of the drug Acipimox, which is a nicotinic acid derivative that is commonly used to treat hypertriglyceridemia and other lipid disorders. The 13C2,15N2 labeling of Acipimox-13C2,15N2 allows researchers to track the metabolic fate of the drug in vivo using stable-isotope tracing techniques. This is particularly useful for studying the effects of Acipimox on different metabolic pathways, as it allows researchers to distinguish between endogenous and exogenous sources of metabolites. Acipimox-13C2,15N2 has been used in a variety of metabolic studies, including investigations into the effects of Acipimox on lipid and glucose metabolism in patients with type 2 diabetes, as well as studies of the metabolic effects of different dietary interventions. In terms of chemical properties, Acipimox-13C2,15N2 is a white crystalline powder that is soluble in organic solvents such as ethanol and methanol. Its chemical formula is C8H4D2N2O2, and its molecular weight is 170.16 g/mol. Overall, Acipimox-13C2,15N2 is a valuable tool for researchers studying metabolic disorders and the effects of drugs on metabolic pathways in the body. Its stable-isotope labeling allows for precise tracking of metabolic pathways and provides valuable insights into the mechanisms of lipid and glucose metabolism.